Xuben Hou

17PUBLICATIONS

29CO-AUTHORS

Metabolic medicineHaematological tumoursCheminformatics and quantitative structure-activity relationshipsNanofabrication, growth and self assemblyModelling and simulation

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (17)

Sort by Publication Date:

|Jun 17, 2026

Targeting N<sup>1</sup>-methyladenosine modification in osteoblasts through tRNA methyltransferase 10C reverses mitochondrial dysfunction and ameliorates osteoporosis.

|Jun 05, 2026

Histone deacetylase enzyme activity is not the universal anticancer target of HDAC inhibitors.

|Apr 28, 2026

Discovery of Benzofuran-2-Carboxylic Acid Derivatives as Potent PTPRO Inhibitors with Oral Efficacy for Treatment of Inflammatory Bowel Disease.

|Feb 24, 2026

Trimbody with rigid AI-designed scaffolds enables atomic-resolution cryo-EM structure determination of small proteins.

Jinyang Song, Lei Qi, Yongyue Li

|Feb 11, 2026

WeMol: A Cloud-Based and Zero-Code Platform for AI-Driven Molecular Design and Simulation.

Haihan Liu, Xin Yan, Hao Fang

|Sep 12, 2024

Development of a First-in-Class DNMT1/HDAC Inhibitor with Improved Therapeutic Potential and Potentiated Antitumor Immunity.

Yingjie Chang, Huahui Guo, Xue Li

Pageof 3

Frequent Collaborators

10 joint publications

Hao Fang

Yingkai Zhang

Yi Zhou

Meng Liu

Jin-Peng Sun

Xiaoting Liu

Wenqiang Chang

Ming Zhang

Xueyang Jin

Haijuan Zhang

Frequent Collaborators

10 joint publications

Hao Fang

3 joint publications

Yingkai Zhang

2 joint publications

Yi Zhou

2 joint publications

Meng Liu